Back to search
No Eye Disorder
Clinical trial pipeline · Data from ClinicalTrials.gov
See which No Eye Disorder trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which No Eye Disorder trials you may qualify forThere is limited local data available on the comparison between surgical blade no.11 and ophthalmic knife among patients with neglected clubfoot going through t…
The goal of the study is to investigate the safety, tolerability and efficacy of up to 3 doses of KIO-301 administered by intravitreal (IVT) injection bilateral…
The DYMOND study evaluates the safety and effectiveness of TrackSight™, a digital medical application designed to slow myopia (nearsightedness) progression in c…
Full-thickness macular hole (MH) is a common sight threatening macular condition with a prevalence of 3.3 per 1000 individuals. Prompt surgical repair of MH is…
The purpose of the study is to investigate whether there is a difference in BCVA in patients who receive one of the following two surgeries: intervention group…
Summary The environment in which we live, play and travel is primarily built by and for people with sight. Navigating the sighted world with blindness can be ex…
This randomized controlled trial evaluates whether providing clinicians with AI-derived quantitative retinal information improves the quality and efficiency of…
Macular hole (MH) is a common condition that affects approximately 1.6/1000 elderly Chinese population. The prevalence is expected to be even higher in individu…